These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14330876)

  • 41. Microbiological control for sterile pharmaceutical products.
    Hall NC
    Bull Parenter Drug Assoc; 1968; 22(4):187-92. PubMed ID: 4914500
    [No Abstract]   [Full Text] [Related]  

  • 42. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR].
    Temprano G; Prats S; Bregni C
    Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proper use of biological indicators in sterilization.
    Brewer JH; Phillips GB
    Bull Parenter Drug Assoc; 1968; 22(4):157-69. PubMed ID: 4914499
    [No Abstract]   [Full Text] [Related]  

  • 44. Examples of NIR based real time release in tablet manufacturing.
    Skibsted ET; Westerhuis JA; Smilde AK; Witte DT
    J Pharm Biomed Anal; 2007 Mar; 43(4):1297-305. PubMed ID: 17166686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality.
    Gikanga B; Chen Y; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(2):284-96. PubMed ID: 25868994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 47. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
    [No Abstract]   [Full Text] [Related]  

  • 49. ["Me-too preparations" or "do we need 25 beta blockers?"].
    Estler CJ
    Med Monatsschr Pharm; 1991 Jul; 14(7):193-4. PubMed ID: 1679520
    [No Abstract]   [Full Text] [Related]  

  • 50. GMPs vs GCPs: United States Pharmacopeia General Chapters.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791
    [No Abstract]   [Full Text] [Related]  

  • 51. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 52. [New trends in the research of the synthetic drugs].
    Hanc O
    Cesk Farm; 1971 Jun; 20(5):165-7. PubMed ID: 5562021
    [No Abstract]   [Full Text] [Related]  

  • 53. Sterile ophthalmic ointment and suspension manufacturing.
    Abshire R; Cash P
    J Parenter Sci Technol; 1986; 40(3):97-9. PubMed ID: 3746580
    [No Abstract]   [Full Text] [Related]  

  • 54. [Industrial-scale experiments on powder mixing].
    Wayer M; Pap A; Kata M
    Acta Pharm Hung; 1980 Jan; 50(1):25-31. PubMed ID: 7361554
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pharmaceutical engineering in drug formulation].
    Bruguera JL; Reynier JP; Rochat MH; Verain A
    J Pharm Belg; 1990; 45(4):274-9. PubMed ID: 2290123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parenteral formulation V: development of analytical methods for a sterile product.
    Mollica JA; Lin KS
    Bull Parenter Drug Assoc; 1971; 25(3):140-8. PubMed ID: 5093250
    [No Abstract]   [Full Text] [Related]  

  • 57. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 59. [Evolution of manufacturing conditions and facilities in the pharmaceutical industry].
    Lhoest W
    J Pharm Belg; 2005; 60(4):109-16. PubMed ID: 16429832
    [No Abstract]   [Full Text] [Related]  

  • 60. Basics of sterile compounding: compounding by weight versus compounding by volume.
    Thoma L
    Int J Pharm Compd; 2014; 18(2):131-4. PubMed ID: 24881117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.